Deceased organ donor screening for human immunodeficiency virus, hepatitis B, and hepatitis C viruses: Discordant serology and nucleic acid testing results

ConclusionsThis study highlights the importance of robust quality‐assurance to minimize NRP NAT results. NAT may allow for increased utilization of organs from HBV‐ and HCV‐ seropositive, NAT‐negative donors.This article is protected by copyright. All rights reserved.

Source: Transplant Infectious Disease - November 27, 2017 Category: Transplant Surgery Authors: Nicole Theodoropoulos, Marek J. Nowicki, Claudia Chinchilla ‐Reyes, Sara Dionne, Andrés Jaramillo, Tom Mone, Richard Hasz, Martin D. Jendrisak, Daniela P. Ladner, Michael G. Ison Tags: Original Report Source Type: research